Representative before the EPO

Employment test 51 - 200 employees
Company dna mathys and squire llp
no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

We have observed 129 EP applications Martin Robert MacLean has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11756091

CATHETER FOR ENDOSCOPE

IPC classification:
A61B 1/00, A61B 17/00, A61B 18/00, A61B 18/12, A61B 18/18, A61B 18/20, A61M 25/00, A61M 31/00
Applicant:
Osaka University
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11792727

COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID SUITABLE FOR HIGH PURIFICATION

IPC classification:
C12P 7/64, C12R 1/89
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11859495

THREE-DIMENSIONAL RETRACTOR

IPC classification:
A61B 17/00
Applicant:
Osaka University
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13179623

Antenna arrangements for implantable therapy device

IPC classification:
A61N 1/372, A61N 1/378, H01Q 1/27, H01Q 1/36, H04B 5/00, A61B 5/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12757520

MAGNETIC PARTICLE SCAVENGING DEVICE AND METHOD

IPC classification:
B01D 43/00, B03C 1/02, B03C 1/10, B03C 1/28, B03C 1/30, C07K 1/22, C12M 1/00, C12N 1/00, C12N 15/10, A23L 1/48, A61K 35/14, A61M 1/38
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12779642

COMPLEMENT FACTOR B ANALOGS AND THEIR USES

IPC classification:
A61K 39/395
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12722486

THERAPEUTIC FUSION PROTEINS

IPC classification:
C07K 7/23, C12N 15/62, A61K 47/48
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11827823

METHOD FOR PREPARATION OF AN AQUEOUS GLYPHOSATE CONCENTRATE

IPC classification:
A01N 25/02, A01N 37/40, A01N 39/02, A01N 39/04, A01N 43/40, A01N 57/20, A01P 13/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP12730288

ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES

IPC classification:
A61K 47/48
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13179177

Suppression of neuroendocrine diseases

IPC classification:
A61P 35/00, C12N 9/00, A61K 38/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12735389

METHOD OF TREATING PATHOLOGIC HETEROTOPIC OSSIFICATION

IPC classification:
A61P 19/08, A61K 31/015, A61K 33/36
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12807960

COMBINATION THERAPY

IPC classification:
A61P 35/00, A61K 39/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12731209

METHOD FOR ASSESSMENT OF HEPATIC FUNCTION AND PORTAL BLOOD FLOW

IPC classification:
G01N 33/50, G01N 33/68
Applicant:
The Regents of the University of Colorado
Agent:
Multiple attorneys, Mathys & Squire LLP
Agent:
Pronovem
Status:
GRANT OF PATENT INTENDED
EP12826189

COMPOSITIONS AND METHODS FOR USE IN PROMOTING LEAN BODY MASS

IPC classification:
A23L 1/30
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12756552

INFLUENZA VIRUS ANTIBODY COMPOSITIONS

IPC classification:
A61P 31/16, C07K 16/10, A61K 39/395
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11806019

CRYSTALLINE GRAPHENE AND METHOD OF MAKING CRYSTALLINE GRAPHENE

IPC classification:
C01B 31/04, C09D 11/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12784342

A TIBIAL COMPONENT

IPC classification:
A61F 2/38
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12841245

LOCALIZED MODULATION OF TISSUES AND CELLS TO ENHANCE THERAPEUTIC EFFECTS INCLUDING RENAL DENERVATION

IPC classification:
C07D 251/18, A61K 35/23, A61K 8/43
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12843980

LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS

IPC classification:
B01D 15/08, A61K 8/14, A61K 9/127, A61K 47/24, A61K 47/28, A61K 47/30
Applicant:
The University of British Columbia
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14159649

Stabilized pharmaceutical formulations comprising antineoplastic compounds

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/19, A61K 31/4188, A61K 47/12
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP12846393

PILE WITH LOW NOISE GENERATION DURING DRIVING

IPC classification:
E02D 5/24, E02D 5/72
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP12784665

NOVEL BACTERIOPHAGES

IPC classification:
A61P 31/02, A61P 31/04, C12N 7/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Agent:
Stratagem IPM Limited
Status:
GRANT OF PATENT INTENDED
EP11838538

METHOD AND SYSTEM FOR SIMULTANEOUSLY FINDING AND MEASURING MULTIPLE ANALYTES FROM COMPLEX SAMPLES

IPC classification:
G01N 1/28, G01N 27/62, H01J 49/26
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP12852917

FILTRATION MODULE

IPC classification:
B01D 11/00
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12855365

ULTRASOUND STYLET

IPC classification:
A61N 7/00, G01N 29/24, A61B 8/12
Applicant:
University of Washington CoMotion
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP12806635

RESPIRATORY INFECTION ASSAY

IPC classification:
C12Q 1/68, C12Q 1/70
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14170802

Methods and compositions for facilitating regeneration

IPC classification:
A61N 7/00, A61N 7/02, C07K 16/46, C12N 1/06
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11725430

SELECTIVE HERBICIDES WITH ACTIVATOR ADJUVANTS

IPC classification:
A01N 25/30, A01N 31/02, A01N 37/44, A01N 41/10, A01N 43/08, A01N 55/00, A01N 59/16, A01P 13/02
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14163682

Increasing levels of nicotinic alkaloids

IPC classification:
C07K 14/415, C12N 15/82, A01H 5/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12842115

FUNCTIONALIZED NANOPARTICLES FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

IPC classification:
G01N 33/53
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12847334

LYSOSOMAL ENZYME ASSAY METHODS AND COMPOSITIONS

IPC classification:
C12N 9/14, C12Q 1/34, G01N 30/72, G01N 33/68
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12805771

IMPROVED PROCESS FOR THE MANUFACTURE OF ALCOHOLIC BEVERAGES AND PRODUCTS PRODUCED BY SUCH PROCESS

IPC classification:
A61Q 5/00, A61Q 5/02, A61Q 19/00, C12C 5/00, C12C 7/28, C12C 11/00, C12G 1/02, C12G 3/02, A61K 8/97
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12795976

METHOD OF TREATING DIABETES USING NON-GLYCOSYLATED APOLIPOPROTEIN A-IV

IPC classification:
A61P 3/10, C07K 14/775, A61K 38/17
Applicant:
University of Cincinnati
Agent:
Michael Richard Moore, Keltie LLP
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13744046

IMPROVEMENTS IN TEAR FILM STABILITY

IPC classification:
A61P 27/02, A61K 31/22, A61K 31/366, A61K 31/40, A61K 31/404
Applicant:
University of Sydney
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13742983

METHOD AND SYSTEM FOR RAPID CONTAINMENT AND INTERVENTION OF A SUBSEA WELL BLOWOUT

IPC classification:
E21B 33/043, E21B 33/064
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP10856006

EYEGLASS CLEANING APPARATUS

IPC classification:
G02C 13/00
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13706397

COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS

IPC classification:
C12N 15/10, C12N 15/70, C12N 15/81, C12N 15/85, C12N 15/86, C40B 40/08, C40B 50/06
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Olga Bezzubova, Jones Day
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12781581

ASSAYS FOR DETECTING ENZYMATIC ACTIVITY

IPC classification:
C12Q 1/37, G01N 33/53, G01N 33/573, G01N 33/86
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13710232

COMPOSITIONS AND METHODS FOR DETECTING ALLOGENEIC MATTER IN A SUBJECT

IPC classification:
C12Q 1/68
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14186256

Biocidal particles of methylated polystyrene

IPC classification:
C08L 25/06, C08L 25/18, A01N 43/64, A01N 43/50, A01N 43/66, A01N 43/76, A01N 59/00, A01P 1/00
Applicant:
Auburn University
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Agent:
Yvonne Catherine Johnson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP12826134

CLOSTRIDIUM DIFFICILE ANTIBODIES

IPC classification:
C07K 16/12, A61K 39/00, A61K 39/40, A61K 45/06
Agent:
John William Graham Jappy, Gill Jennings & Every LLP
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Agent:
Christina Gates, Tomkins & Co
Status:
EXAMINATION IN PROGRESS
EP13767724

APTAMERS TO PDGF AND VEGF AND THEIR USE IN TREATING PDGF AND VEGF MEDIATED CONDITIONS

IPC classification:
C12Q 1/68
Applicant:
Somalogic Inc
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13712661

DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS

IPC classification:
C12N 7/00, C12N 15/86
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13712933

MALE STERILE GARLIC PLANTS, HYBRID OFFSPRING OF SAME AND METHODS OF GENERATING AND USING SAME

IPC classification:
A01H 3/02, A01H 5/00, A01H 5/06
Applicant:
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13775400

CHLORIDE PROCESS FOR THE LEACHING OF GOLD

IPC classification:
C22B 3/10, C22B 3/24, C22B 3/30, C22B 3/44, C22B 11/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13775203

PROCESS FOR EXTRACTION OF RARE EARTH ELEMENTS

IPC classification:
C22B 3/10, C22B 3/24, C22B 3/26, C22B 3/44, C22B 59/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP13775010

A METHOD TO ENHANCE CELL NUCLEATION DENSITY IN SOLID-STATE FOAMS

IPC classification:
C08J 5/18, C08J 9/00, C08J 9/30, C08L 1/00, C08L 75/04
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13778883

WEARABLE PEDICURE PROTECTION DEVICE

IPC classification:
A43B 7/26
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12810860

COMPOSITIONS AND METHODS FOR OVERCOMING RESISTANCE TO TRAMADOL

IPC classification:
A61K 9/22, A61K 9/28, A61K 31/135
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12720560

ANTI-MICROBIAL DRINKING OR EATING VESSEL

IPC classification:
B65D 23/08, C03C 17/00, C03C 17/34, C09D 5/14, C09D 5/16, A47G 19/12, A47G 19/22
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13715732

CLOSTRIDIUM DIFFICILE ANTIGENS

IPC classification:
C07K 14/33, A61K 39/08
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13790774

CLINICAL DIAGNOSTIC SYSTEMS

IPC classification:
C12M 1/00, C12M 1/34, C12Q 1/00, G01N 21/00, G01N 21/66, G01N 21/76, G01N 27/30, G01N 27/327, G01N 27/416, G01N 33/53, G01N 33/533, G01N 33/536, G01N 33/543, G01N 33/566, G01N 33/58
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12788870

AN AIRLESS TYRE FOR VEHICLES

IPC classification:
B60B 9/00, B60C 7/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13729229

BENZO [C]ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 498/04, A61K 31/424, A61K 31/55
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
The patent has been granted
EP13729231

BENZO [B]ISOXAZOLOAZEPINE BROMODOMAIN INHIBITORS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 498/04, A61K 31/424, A61K 31/55
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11755607

BACTERIAL VACCINE COMPONENTS FROM STAPHYLOCOCCUS AUREUS AND USES THEREOF

IPC classification:
A61P 31/04, A61P 37/04, C07K 14/31, C12N 15/31, C12Q 1/68, G01N 33/569, G01N 33/68, A61K 39/00, A61K 39/085
Applicant:
Université de Montréal
Agent:
Hoffmann Eitle PartmbB
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13156237

Method of delivering a polynucleotide into a cell

IPC classification:
C08F 293/00, C12N 15/11, C12N 15/87, A61K 31/7088, A61K 47/34, A61K 47/48
Applicant:
The University of Washington
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13817200

SLEEP ASSISTANCE ARTICLE AND RELATED METHODS OF USE

IPC classification:
A61M 21/02
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP13722007

THERAPEUTIC BACTERIOPHAGE COMPOSITIONS

IPC classification:
A61K 35/76
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13825899

COMPOSITIONS AND METHODS FOR IMPROVING NANOPORE SEQUENCING

IPC classification:
C12N 15/11, C12Q 1/68, G01N 27/26, G06F 19/10
Applicant:
University of Washington CoMotion
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13825885

PRODUCTION OF SOLUBLE PROTEIN PRODUCTS FROM HEMP ("H701")

IPC classification:
A23J 1/14, A23J 3/14, A23L 1/305, A23L 2/66
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13753495

METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

IPC classification:
C07K 14/705, C12N 5/10, C12N 15/62, A61K 39/395
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13759562

FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATING PAIN

IPC classification:
C12N 9/52, C12N 9/54, C12N 15/62, A61K 38/48, A61K 47/48
Applicant:
ALLERGAN INC
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP15156823

Transplantation of human neural cells for treatment of neurodegenerative conditions

IPC classification:
C12N 5/00, A01N 63/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13785585

ASSAY FOR ASSESSMENT OF ENDOSOMAL TRANSPORT

IPC classification:
G01N 33/50
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13850828

WATER TREATMENT COMPOSITION AND METHOD OF USING SAME

IPC classification:
C02F 1/56, C02F 1/58
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13811605

RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS

IPC classification:
C07K 14/33, A61K 38/48
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13853943

DISEASE SEVERITY INDEX FOR ASSESSMENT OF CHRONIC LIVER DISEASE AND METHOD FOR DIAGNOSIS OF THREE DISTINCT SUBTYPES OF PRIMARY SCLEROSING CHOLANGITIS

IPC classification:
B01L 3/14, G01N 27/62, A61K 31/575, A61K 35/14, A61K 38/00, A61K 38/17, A61K 51/04
Applicant:
The Regents of the University of Colorado
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13814726

METHODS FOR SCREENING

IPC classification:
C07K 14/435
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP13814341

LIPOCALIN FUSION PARTNERS

IPC classification:
C07K 14/435
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13864605

METHODS FOR PREPARING AND COMPOSITIONS COMPRISING PLANT-BASED OMEGA-3 FATTY ACIDS

IPC classification:
A23L 1/36
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13865950

ANTIMICROBIAL COMPOUNDS, THEIR SYNTHESIS AND APPLICATIONS THEREOF

IPC classification:
A61K 38/05
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14704241

ENERGY EFFICIENT NEUROMODULATION

IPC classification:
A61N 1/36
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP13802091

CRIMEAN-CONGO HAEMORRHAGIC FEVER VIRUS ANTIGENIC COMPOSITION

IPC classification:
C12N 5/10, C12N 15/40, C12N 15/70, C12N 15/861, C12N 15/863, A61K 39/12
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14706942

THERAPEUTICS FOR SUPPRESSING OSTEOPOROSIS

IPC classification:
A61P 19/10, A61K 47/48
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14754394

DEVICE, METHOD, AND SYSTEM FOR MONITORING THE DELIVERY OF FLUIDS THROUGH A DRIP CHAMBER

IPC classification:
A61M 5/168
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15178381

ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF

IPC classification:
C07K 14/435, C07K 16/28, C07K 16/42, C12N 5/10, C12P 21/08, C40B 40/06, C40B 40/08, A61K 39/395
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14768470

DEPOSITING NANOSCALE MATERIALS WITHIN COATED NETWORKED NANOFIBERS

IPC classification:
C01B 31/04, C01D 3/00, C04B 35/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14774732

ANTIBODIES TARGETED TO FUNGAL CELL WALL POLYSACCHARIDES

IPC classification:
A61P 31/10, A61K 36/06, A61K 47/48
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14723919

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

IPC classification:
A61P 35/00, C07D 487/04, A61K 31/437
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14769157

METHODS OF MAKING NANOFIBER ELECTRODES FOR BATTERIES

IPC classification:
H01M 4/02, H01M 4/24, H01M 4/32, H01M 4/34
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14764246

ORGANIC MATERIAL GRINDER AND CIGARETTE FILLER

IPC classification:
B02C 18/00, A24B 5/00, A24C 5/42
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15190286

GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING SIMIAN LENTIVIRAL VECTOR PSEUDOTYPED WITH SENDAI RNA VIRUS SPIKE PROTEIN

IPC classification:
A61P 11/00, C07K 14/47, C12N 5/071, C12N 5/10, C12N 7/00, C12N 15/86, C12N 15/867, A61K 9/00, A61K 35/76, A61K 38/00, A61K 38/16, A61K 38/17, A61K 48/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14725919

LENTIVIRAL VECTORS WITH TROPISM TO MOTOR NEURONS COMPRISING AN ANTIBODY THAT BINDS TO A PRE-SYNAPTIC TERMINAL RECEPTOR ON THE NEUROMUSCULAR JUNCTION AND A FUSOGENIC PROTEIN

IPC classification:
C12N 15/86, A61K 48/00
Applicant:
Imperial Innovations Limited
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP11822941

COMPANION ANIMAL CANCER TREATMENTS WITH AN ANTI P2X7 ANTIBODY

IPC classification:
A61P 35/00, C07K 16/28, C07K 16/30, A61K 39/395
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
The patent has been granted
EP14800779

TRANS-TUMORAL PEPTIDE SPECIFIC TO NEUROPILIN AND FUSION PROTEIN HAVING SAME PEPTIDE FUSED THEREIN

IPC classification:
A61P 35/00, C07K 14/435, C07K 19/00, A61K 38/17
Applicant:
Ajou University Industry-Academic Cooperation Foundation
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP14804718

STIMULI-RESPONSIVE MAGNETIC NANOPARTICLES

IPC classification:
A61K 49/18
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP14810485

USE OF RESISTANT STARCHES IN COATING COMPOSITIONS

IPC classification:
A23L 7/10, A23P 20/00, A23L 29/212, A23P 30/20, A23L 7/157, A23L 3/3562
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15182208

ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES

IPC classification:
A61K 47/48
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14742647

METHOD OF REDUCING SCARRING

IPC classification:
A61K 9/00, A61K 31/05, A61K 47/38, A61L 26/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12705517

APOLIPOPROTEIN AIV AS AN ANTIDIABETIC PEPTIDE

IPC classification:
C07K 9/00, C07K 14/00, A61K 39/395
Applicant:
University of Cincinnati
Agent:
Michael Richard Moore, Keltie LLP
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14739923

SUPPRESSION OF ITCH

IPC classification:
A61P 25/00, A61K 38/48, A61K 39/08
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14747697

CATIONIC NEUROTOXINS

IPC classification:
C07K 14/33, A61K 39/08
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11820471

AMINOPYRIDINE- AND AMINOPYRIMIDINECARBOXAMIDES AS CXCR2 MODULATORS

IPC classification:
C07D 213/82, C07D 239/47, C07D 401/12, C07D 413/12, C07F 5/02, C07F 5/04, A01N 43/54, A61K 31/44, A61K 31/505, A61K 31/69
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Agent:
Bernadette Angelina Hambleton, Sterling IP
Status:
EXAMINATION REQUESTED
EP15202190

MSP NANOPORES AND RELATED METHODS

IPC classification:
C07K 14/35, C12N 15/31, C12N 15/63, C12R 1/32, G01N 33/68
Applicant:
The University of Washington
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP13750432

2- [5- [N- (4 -FLUOROPHENYL) CARBAMOYL]PYRIMIDIN- 2 - YLSULFANYLMETHYL]-4- (TRIFLUOROMET HOXY) PHENYL]BORONIC ACID

IPC classification:
A61P 29/00, C07F 5/02, A61K 31/505, A61K 31/69
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP14841122

SELECTIVE MODIFICATION OF POLYMER SUBUNITS TO IMPROVE NANOPORE-BASED ANALYSIS

IPC classification:
B01D 57/02, B01D 59/42, C07H 21/02, C12P 21/06
Applicant:
University of Washington CoMotion
Applicant:
Illumina, Inc.
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP15195939

METHODS AND SYSTEMS FOR GLUCOSE REGULATION

IPC classification:
A61N 1/36, A61N 1/372
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14846407

CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF

IPC classification:
C12N 9/96, A61K 38/02, A61K 38/07
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP12180143

Web comprising fine fiber and reactive, adsorptive or absorptive particulate

IPC classification:
B01D 39/00, B01D 39/04, B01D 39/14, B01D 39/16, C12M 1/12, C12N 5/00
Applicant:
Donaldson Company, Inc.
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP13886631

BLOOD PUMP CONTROL SYSTEM AND BLOOD PUMP SYSTEM

IPC classification:
A61M 1/10, A61M 1/12
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
GRANT OF PATENT INTENDED
EP11715607

POXVIRUS EXPRESSION SYSTEM

IPC classification:
C12N 15/863, A61K 39/00
Applicant:
Oxford University Innovation Ltd
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION IN PROGRESS
EP12195158

Therapeutic agents containing bacteriophages against P. aeruginosa

IPC classification:
A61P 31/00, A61K 35/76
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729792

STIMULI-RESPONSIVE POLYMER DIAGNOSTIC ASSAY COMPRISING MAGNETIC NANOPARTICLES AND CAPTURE CONJUGATES

IPC classification:
B82Y 25/00, C12N 15/10, G01N 33/543, G01N 33/553, G01N 33/58
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
PATENT GRANTED
EP11827822

METHOD FOR PREPARATION OF AN AQUEOUS GLYPHOSATE CONCENTRATE COMPOSITION HAVING MIXTURE OF AMINE SALTS

IPC classification:
A01N 25/02, A01N 37/40, A01N 39/02, A01N 39/04, A01N 43/40, A01N 57/20, A01P 13/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12195358

Treatment of diseases

IPC classification:
A61P 17/06, A61P 25/00, A61P 25/28, A61P 37/00, C07K 16/06, C07K 16/10, A61K 39/395, A61K 39/42
Applicant:
Aimsco Limited
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14862645

RANDOM COPOLYMER THERAPEUTIC AGENT CARRIERS AND ASSEMBLIES THEREOF

IPC classification:
A61P 31/00, A61K 9/14
Applicant:
University of Washington CoMotion
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16166730

LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS

IPC classification:
B01F 1/00, A61K 9/107, A61K 9/127, A61K 31/704, A61K 49/00
Applicant:
The University of British Columbia
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP11807966

INACTIVATED POLIOVACCINE

IPC classification:
A61P 31/14, C12N 7/04, A61K 39/13
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14810069

IONIZABLE CATIONIC LIPID FOR RNA DELIVERY

IPC classification:
C07C 235/12, C07C 271/22, C07C 323/52, C07C 333/04, C07J 31/00, C12N 15/11, A61K 9/127
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16162611

HAND OPERATED REACHING DEVICE FOR REMOVING TICKS FROM ANIMALS OR HUMANS

IPC classification:
A61B 17/50
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
The patent has been granted
EP11797376

HERBICIDAL PICOLINIC ACID SALT COMPOSITION

IPC classification:
A01N 25/02, A01N 43/40, A01P 13/02
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14865172

BORON NITRIDE AND METHOD OF PRODUCING BORON NITRIDE

IPC classification:
B82Y 30/00, B82Y 40/00, C01B 21/064
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14864396

CARBONACEOUS SUBSTANCE GASIFICATION DEVICE AND METHOD

IPC classification:
C10J 3/04, C10J 3/48, C10J 3/52
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP14863389

CARBONACEOUS SUBSTANCE REACTION SYSTEM AND METHOD

IPC classification:
C10J 3/48, C10J 3/84
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15703188

ORAL SUCTION DEVICE

IPC classification:
A61M 16/04
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15741428

VENOUS ACCESS DEVICE

IPC classification:
A61B 5/15, A61B 5/155
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
The patent has been granted
EP16173070

SAFETY FEATURES FOR USE IN MEDICAL DEVICES

IPC classification:
A61N 1/02, A61N 1/05, A61N 1/36, A61N 1/372, A61N 1/378
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP15723281

DRINKING OR EATING VESSEL

IPC classification:
G03G 7/00
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
The patent has been granted
EP15764318

ANTIBODIES AND METHODS FOR THE DETECTION OF CELL DEATH

IPC classification:
C07K 16/18, G01N 33/53, G01N 33/58
Agent:
Multiple attorneys, Mathys & Squire LLP
Status:
APPLICATION WITHDRAWN
EP16182449

FILTER WEB COMPRISING FINE FIBER AND REACTIVE, ADSORPTIVE OR ABSORPTIVE PARTICULATE

IPC classification:
B01D 39/00
Applicant:
Donaldson Company, Inc.
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Agent:
Valea AB
Status:
EXAMINATION REQUESTED
EP15789449

METHODS FOR ASSESSING DIFFERENTIAL RISK FOR DEVELOPING HEART FAILURE

IPC classification:
G01N 33/68
Applicant:
University of Maryland Baltimore
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP16189999

CHLOROTOXIN VARIANTS, CONJUGATES AND METHODS FOR THEIR USE

IPC classification:
C07K 14/435, C07K 19/00, G01N 33/574, A61K 38/17, A61K 47/42, A61K 49/00
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
Request for examination was made
EP15822249

AQUEOUS SEAWEED EXTRACT IN THE FORM OF A SOLUTION CONCENTRATE

IPC classification:
C05F 11/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
EXAMINATION REQUESTED
EP17154062

CARRIER FOR TARGETING NERVE CELLS

IPC classification:
C07K 14/195, C07K 14/33, A61K 38/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
Request for examination was made
EP15775291

CARBURETED ENGINE HAVING AN ADJUSTABLE FUEL TO AIR RATIO

IPC classification:
F02M 7/12, F02M 35/10
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
Request for examination was made
EP17150909

ASSAY FOR ASSESSMENT OF ENDOSOMAL TRANSPORT

IPC classification:
G01N 33/50
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
Request for examination was made
EP15843087

GLYCOPEPTIDES AND USES THEREOF

IPC classification:
A61K 47/50, C07K 9/00
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
Request for examination was made
EP17163180

SUPPRESSION OF CANCER

IPC classification:
A61P 35/00, A61K 47/50, A61K 47/60, A61K 47/64, C07K 14/33, C07K 14/475, C07K 14/485, C07K 14/495, C07K 14/50, C07K 14/52, C07K 14/54, C07K 14/65, C07K 14/705, C12N 9/50, C12N 9/52, A61K 38/48
Agent:
Martin Robert MacLean, Mathys & Squire LLP
Status:
The application has been published

Please Sign in to use this feature